Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Ptc Therapeutics (PTCT)
Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,923,558
  • Shares Outstanding, K 75,345
  • Annual Sales, $ 698,800 K
  • Annual Income, $ -559,020 K
  • 60-Month Beta 0.37
  • Price/Sales 2.77
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PTCT with:

Options Overview Details

View History
  • Implied Volatility 46.83% ( -11.85%)
  • Historical Volatility 107.71%
  • IV Percentile 13%
  • IV Rank 37.16%
  • IV High 100.86% on 04/18/23
  • IV Low 14.90% on 09/08/23
  • Put/Call Vol Ratio 145.93
  • Today's Volume 2,057
  • Volume Avg (30-Day) 792
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 6,321
  • Open Int (30-Day) 3,674

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -1.01
  • Number of Estimates 9
  • High Estimate -0.58
  • Low Estimate -1.48
  • Prior Year -1.53
  • Growth Rate Est. (year over year) +33.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.57 +5.33%
on 09/19/23
41.93 -40.81%
on 09/07/23
-14.98 (-37.64%)
since 08/21/23
3-Month
23.57 +5.33%
on 09/19/23
43.31 -42.69%
on 06/22/23
-18.24 (-42.36%)
since 06/21/23
52-Week
23.57 +5.33%
on 09/19/23
59.84 -58.52%
on 05/22/23
-25.57 (-50.74%)
since 09/21/22

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors...

PTCT : 24.82 (-2.78%)
CHMP Delivers Opinion on Translarna™ for Conversion to Full Authorization

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

PTCT : 24.82 (-2.78%)
PTC Therapeutics' 2023 STRIVE Awards Program Funds Initiatives Supporting the Duchenne Patient Community

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the two recipients of its 2023 STRIVE Awards for Duchenne Muscular Dystrophy. Through the...

PTCT : 24.82 (-2.78%)
PTC Therapeutics to Participate at Upcoming Investor Conferences

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: Citi 2023...

PTCT : 24.82 (-2.78%)
PTC Therapeutics: Q2 Earnings Snapshot

PTC Therapeutics: Q2 Earnings Snapshot

PTCT : 24.82 (-2.78%)
PTC Therapeutics Provides Corporate Update and Reports Second Quarter Financial Results

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and financial results for the second quarter ending June 30, 2023. "I...

PTCT : 24.82 (-2.78%)
CHMP Recommends Evrysdi® for Babies Under Two Months Old with Spinal Muscular Atrophy

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...

PTCT : 24.82 (-2.78%)
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2023 Financial Results

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its second quarter 2023...

PTCT : 24.82 (-2.78%)
PTC Therapeutics Co-Founder Allan Jacobson, Ph.D., Awarded 2023 Gruber Genetics Prize

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Allan Jacobson, Ph.D., co-founder of PTC and member of the Board of Directors, was...

PTCT : 24.82 (-2.78%)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on July 13, 2023, the company approved non-statutory stock options to purchase an...

PTCT : 24.82 (-2.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

See More

Key Turning Points

3rd Resistance Point 27.08
2nd Resistance Point 26.43
1st Resistance Point 25.62
Last Price 24.82
1st Support Level 24.17
2nd Support Level 23.52
3rd Support Level 22.71

See More

52-Week High 59.84
Fibonacci 61.8% 45.98
Fibonacci 50% 41.70
Fibonacci 38.2% 37.42
Last Price 24.82
52-Week Low 23.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar